Versatile Nanomaterials That Interfere with Ferroptosis in the Tumor Microenvironment

Area of Science:

• Biomedical Engineering
• Oncology
• Cell Biology

Background:

• Ferroptosis is a programmed cell death pathway crucial in cancer biology, driven by iron accumulation and glutathione depletion.
• Tumor cells' high iron demand creates a vulnerability exploitable for inducing ferroptosis.
• Nanomaterials present unique advantages for modulating ferroptosis in cancer therapy.

Purpose of the Study:

• To review recent advancements in nanomaterial-based ferroptosis regulation for tumor cells.
• To assess the current landscape, emerging trends, and therapeutic applications of nanomaterials in this field.
• To explore mechanisms by which nanomaterials modulate ferroptosis, including iron ion regulation, glutathione activity, and lipid peroxidation.

Main Methods:

• Literature review of current research on ferroptosis and nanomaterial applications in oncology.
• Analysis of nanomaterial properties relevant to targeting cancer cells and inducing/inhibiting ferroptosis.
• Synthesis of information on mechanisms of ferroptosis regulation by nanomaterials.

Main Results:

• Nanomaterials demonstrate significant potential in targeting tumor cells, improving drug efficacy, and minimizing side effects.
• Specific strategies involve modulating iron ion homeostasis and interfering with glutathione synthesis and lipid peroxidation pathways.
• Diverse nanomaterial designs offer tailored approaches to induce or inhibit ferroptosis.

Conclusions:

• Nanomaterials hold considerable therapeutic promise for cancer treatment by precisely controlling ferroptosis.
• Targeted modulation of ferroptosis pathways using nanomaterials could lead to novel treatment strategies for various diseases.
• Further development of nanomaterial-based ferroptosis inducers/inhibitors is anticipated to expand therapeutic options.